Summary:

«Venture capital used to be a cottage industry, with very few investing in tomorrow’s products and services. Oh, how times have changed! While there are more startups than ever, there’s also more money chasing them. In this series, we look at the new (or relatively new) VCs in the early stages: seed and Series A.»

«Rooke has over a decade of investing experience beginning at Fidelity Biosciences in 2006 as a Kauffman Fellow. After Fidelity, she helped establish the investing function at the Gates Foundation funding companies in genetic engineering, diagnostics, and synthetic biology. She began 5 Prime Ventures in 2014 using the largest life sciences syndicate on AngelList and achieving one of the highest-performing AngelList syndicates in any sector. Her prior investments include Zymergen, Caribou, Accuri (acquired by Becton Dickinson), and Topaz (acquired by Sanofi).»

Article written by Steven Loeb

19|08|2022

Source:

Vator News

https://vator.tv/news/2022-08-19-meet-jenny-rooke-founder-and-managing-partner-at-genoa-ventures